Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 4/20 | 0.40 |
| ▸ | AKT1 | P31749 | 3/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.39 |
| ▸ | GPR52 | Q9Y2T5 | 6/20 | 0.38 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.37 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.37 |
| ▸ | CDC7 | O00311 | 2/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4331608 | 0.89 | PIK3CD (0.40) | PIK3CDPIK3CARPS6KB1AKT1FGFR4 | |
| SCHEMBL4316571 | 0.83 | PIK3CD (0.43) | PIK3CDPIK3CARPS6KB1AKT1NAMPT | |
| SCHEMBL4316563 | 0.81 | PIK3CD (0.43) | PIK3CDPIK3CARPS6KB1AKT1FGFR4 | |
| SCHEMBL5482150 | 0.77 | PLA2G2A (0.45) | CDC7 | |
| SCHEMBL4325835 | 0.73 | PIK3CD (0.43) | PIK3CDPIK3CAGPR52NAMPTTDO2 | |
| SCHEMBL4325828 | 0.72 | PIK3CD (0.42) | PIK3CDPIK3CANAMPTTDO2EGFR | |
| SCHEMBL4325897 | 0.72 | LCK (0.42) | — | |
| SCHEMBL5495693 | 0.71 | MKNK1 (0.46) | PIK3CDPIK3CARPS6KB1AKT1FGFR4 | |
| SCHEMBL1987155 | 0.70 | FGFR4 (0.49) | PIK3CDPIK3CAFGFR4TDO2EGFR | |
| SCHEMBL5550889 | 0.70 | PLA2G2A (0.47) | CDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRM1, GRIN1, GRM2 | PIK3CD 1880/4885PIK3CA 2244/4885RPS6KB1 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.